Scott C. Kachlany
Founder presso Actinobac Biomed, Inc.
Profilo
Scott C.
Kachlany is the founder of Actinobac Biomed, Inc. which was founded in 2009.
He holds the title of Chief Scientific Officer at Actinobac Biomed, Inc. Dr. Kachlany's current job is as a Director at Leukovet.
Dr. Kachlany's former job was as an Associate Professor at the University of Medicine & Dentistry of New Jersey.
Dr. Kachlany obtained a doctorate degree from The Trustees of Columbia University in The City of New York in 2001 and an undergraduate degree from Cornell University in 1997.
Posizioni attive di Scott C. Kachlany
| Società | Posizione | Inizio |
|---|---|---|
Actinobac Biomed, Inc.
 Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Founder | 17/07/2009 |
Leukovet
 Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Director/Board Member | - |
Precedenti posizioni note di Scott C. Kachlany
| Società | Posizione | Fine |
|---|---|---|
| University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | - |
Formazione di Scott C. Kachlany
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Health Technology |
Leukovet
Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Health Technology |
- Borsa valori
- Insiders
- Scott C. Kachlany
